文献速递慢性肾脏病遗传性与小管间质肾病

人工智能在常染色体显性多囊肾病中的临床应用

Clinical applications of artificial intelligence in autosomal dominant polycystic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

本文综述人工智能在常染色体显性多囊肾病(ADPKD)中的临床应用。AI影像工具可提升总肾脏体积测量的精度与效率,机器学习整合遗传、影像和临床数据预测肾功能下降,并用于识别遗传变异、优化临床试验设计,但临床整合仍存争议与挑战。

要点

  • AI影像工具提升总肾脏体积测量精度与效率,助力监测疾病进展。
  • 机器学习整合多源数据预测肾功能下降,支持个体化治疗策略。
  • AI可优化临床试验的患者选择、疗效预测与安全监测。

核心结论

  • AI在ADPKD的诊断、风险分层、管理和预后方面展现出推动精准医学的潜力。

研究设计与样本

  • 综述,围绕AI在ADPKD诊断、风险分层、管理、预后及临床试验设计中的临床应用进行总结。

主要发现

  • AI影像工具可提升总肾脏体积测量的精度与效率,并更可靠地评估治疗反应。
  • 机器学习算法整合遗传、影像和临床数据可预测肾功能下降,促进个体化治疗。
  • AI用于识别遗传变异并细化基因型-表型关系。
  • AI支持纵向追踪MRI或CT获得的总肾脏体积测量。
  • AI可优化临床试验设计,改善患者选择、治疗反应预测与安全监测。

临床怎么用

  • 可将AI影像工具用于ADPKD患者总肾脏体积的测量与纵向监测。
  • 可利用机器学习整合多源数据辅助预测肾功能下降与个体化治疗决策。
  • 需注意AI临床整合仍存争议与挑战。

局限性

  • AI整合到临床实践仍存争议,并可能带来若干挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disorder leading to kidney failure. Recent advancements in artificial intelligence (AI) are transforming the diagnosis, risk stratification, management and prognostication in ADPKD by enabling more accurate assessments and individualized care. AI-powered imaging tools enhance the measurement of total kidney volume (TKV), improving the precision and efficiency of monitoring disease progression and more reliable assessment of therapeutic response. Machine learning algorithms can integrate genetic, imaging and clinical data to predict kidney function decline, facilitating personalized treatment strategies. In addition, AI is being used to identify genetic variants and to refine genotype-phenotype relationships, offering deeper insights into disease variability. AI-enabled monitoring technologies can support longitudinal tracking of TKV measurements obtained through magnetic resonance imaging or computed tomography, thereby improving clinical decision-making and management. Furthermore, AI can optimize clinical trial design by improving patient selection, prediction of treatment responses and safety monitoring. Despite these promising developments, integrating AI into the clinical practice remains controversial and may pose several challenges. This review highlights the emerging clinical applications of AI in ADPKD, emphasizing its potential to advance precision medicine and improve patient outcomes.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Ebrahimi N, Cheungpasitporn W, Chebib FT, et al. Clinical applications of artificial intelligence in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2026. PMID: 41591418. doi:10.1093/ndt/gfag010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。